428 results on '"Chang, D.T."'
Search Results
102. NOVEL TOUCH-FREE DRIVE, SENSE, AND TUNING MECHANISM FOR ALL-DIELECTRIC MICRO-SHELL GYROSCOPE
103. A Phase 2 Multicenter Study to Evaluate Gemcitabine and Fractionated Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Adenocarcinoma
104. Plasma SPARC Following Stereotactic Body Radiation Therapy (SBRT) Predicts for Progression-Free Survival in Locally-Advanced Pancreatic Cancer
105. Clinical and Dosimetric Predictors of Perioperative Pulmonary Complications in Esophageal Cancer Patients Treated With Neoadjuvant Chemoradiation
106. SMAD4 Inactivation and Prognosis in Colorectal Cancer
107. Predicting Liver Volume Changes After Stereotactic Body Radiation Therapy for Liver Tumors
108. Anemia During Radiation Therapy Correlates With Outcomes in Pancreatic Cancer
109. Factors that Determine Academic Versus Private Practice Career Interest in Radiation Oncology Residents in the United States: Results of a Nationwide Survey
110. 18Flurodeoxyglucose-PET Baseline Avidity Predicts for Inferior Outcomes in Patients With Locally-Advanced Pancreatic Cancer Treated With Gemcitabine and Stereotactic Body Radiation Therapy
111. Brain Metastases and Resection Cavities From Colorectal Carcinoma Treated With Stereotactic Radiosurgery Have Poor Local Control Compared to Noncolorectal Histology
112. Risk of Hepatobiliary Toxicity After SBRT to the Liver for Central Liver Tumors
113. Generation of Consensus Contour Atlas for Esophageal Cancer IMRT
114. Modeling approach to analyze bonding stress in UHF quartz resonators
115. A Phase 2 Multi-institutional Study to Evaluate Gemcitabine and Fractionated Stereotactic Radiotherapy for Unresectable, Locally Advanced Pancreatic Adenocarcinoma
116. Reduced Toxicity in Inflammatory Bowel Disease Patients Treated With Intensity Modulated Radiation Therapy (IMRT)
117. SBRT as a Novel Treatment Option for Locally Recurrent Pancreatic Cancer After Failure of Definitive Multimodality Therapy: A Multi-institutional Case Series
118. Normal Tissue Complication Probability Modeling of Acute Hematologic Toxicity in Patients Receiving Pelvic IMRT and Concurrent Chemotherapy
119. Noninterventional study HEXAFIL: Interim analysis of G-CSF-supported chemotherapy regimens in elderly patients
120. Multimodality Therapy for Esophageal Cancer: The Benefit of Chemoradiation
121. Normal Tissue Complication Probability Modeling of Acute Hematologic Toxicity in Patients with Squamous Cell Carcinoma of the Anal Canal Treated with Definitive Chemoradiotherapy
122. Effect of Chemoradiotherapy before and after Surgery for Esophageal Cancer: A SEER-Medicare Analysis
123. Gastrointestinal Normal Tissue Toxicity Prediction In Stereotactic Body Radiotherapy
124. Radiotherapy For Adenoid Cystic Carcinomas Of The Head and Neck: Clinical Outcomes And Patterns Of Failure
125. Dosimetric Comparison of RapidArc versus CyberKnife for Stereotactic Body Radiation Therapy for Pancreatic Cancer
126. Postchemoradiotherapy Positron Emission Tomography for Predicting Survival in Patients with Esophageal Cancer
127. F611 FENTANYL BUCCAL TABLETS FOR BREAKTHROUGH CANCER PAIN TREATMENT - RESULTS OF A NON-INTERVENTIONAL STUDY EVALUATING ITS ROUTINE USE IN GERMANY/AUSTRIA
128. Combined Modality Therapy for Rectal Cancer: Analysis of Potential Differences in Disease Presentation, Treatment Adherence, and Treatment Outcome According to Race
129. Rectal Deformation and Displacement during Pre-operative Radiotherapy for Rectal Cancer: Insights from Mid-treatment Cone-beam Computed Tomography
130. Comparison of RapidArc vs. Conventional Intensity Modulated Radiation Therapy for Stereotactic Body Radiation Therapy for Pancreatic Cancer
131. Intensity Modulated Radiation Therapy vs. Conventional Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal
132. Liver Tumor Motion using Different Fiducial Landmarks
133. Intensity Modulated Radiotherapy for Tumors of the Nasal Cavity and Paranasal Sinuses: Clinical Outcomes and Patterns of Failure
134. Cost Effectiveness of Radiotherapy in Locally Advanced Pancreatic Cancer
135. Significant Duodenal Dose Variation within the Respiratory Cycle during Stereotactic Body Radiotherapy for Pancreatic Cancer
136. Stereotactic Body Radiotherapy for Colorectal Liver Metastases: A Pooled Analysis
137. Cyclin-dependent Kinase Inhibitor 2A (p16ink4a) Expression is Associated with Improved Survival in Patients with Pancreatic Adenocarcinoma
138. Intensity Modulated Radiotherapy for Adenocarcinoma of the Pancreas
139. Duodenal Toxicity in Single-fraction Stereotactic Body Radiotherapy
140. Stereotactic Body Radiotherapy for Unresectable Adenocarcinoma of the Pancreas
141. Phase II Trial of Single Fraction Stereotactic Body Radiotherapy Delivered by Trilogy Linear Accelerator for the Treatment of Locally Advanced Adenocarcinoma of the Pancreas
142. Positron Emission Tomography for Predicting Pathologic Response Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
143. Intensity Modulated Radiotherapy for Squamous Cell Carcinoma of the Hypopharynx and Larynx: Clinical Outcomes and Patterns of Failure
144. Intensity Modulated Radiotherapy for Gastric Cancers: Toxicity and Clinical Outcome
145. Salvage Re-irradiation using Intensity-modulated Radiotherapy for Squamous Cell Carcinoma of the Head and Neck
146. Intensity Modulated Radiotherapy for Non-Hodgkin's Lymphoma of Waldeyer's Ring for Parotid Preservation
147. 2901
148. MEMS-based quartz oscillators and filters for on-chip integration
149. A NEW MEMS-BASED QUARTZ RESONATOR TECHNOLOGY
150. COMPENSATED TUNABLE CAPACITIVE THIN FILM HYDROGEN SENSOR
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.